Spinocerebellar ataxia: an update
R Sullivan, WY Yau, E O'Connor, H Houlden - Journal of neurology, 2019 - Springer
Spinocerebellar ataxia (SCA) is a heterogeneous group of neurodegenerative ataxic
disorders with autosomal dominant inheritance. We aim to provide an update on the recent …
disorders with autosomal dominant inheritance. We aim to provide an update on the recent …
Polyglutamine spinocerebellar ataxias—from genes to potential treatments
HL Paulson, VG Shakkottai, HB Clark… - Nature Reviews …, 2017 - nature.com
The dominantly inherited spinocerebellar ataxias (SCAs) are a large and diverse group of
neurodegenerative diseases. The most prevalent SCAs (SCA1, SCA2, SCA3, SCA6 and …
neurodegenerative diseases. The most prevalent SCAs (SCA1, SCA2, SCA3, SCA6 and …
N omenclature of genetic movement disorders: R ecommendations of the international P arkinson and movement disorder society task force
C Marras, A Lang, BP van de Warrenburg… - Movement …, 2016 - Wiley Online Library
The system of assigning locus symbols to specify chromosomal regions that are associated
with a familial disorder has a number of problems when used as a reference list of …
with a familial disorder has a number of problems when used as a reference list of …
Desaturase and elongase-limiting endogenous long-chain polyunsaturated fatty acid biosynthesis
JY Zhang, KSD Kothapalli… - Current Opinion in Clinical …, 2016 - journals.lww.com
Desaturase and elongase-limiting endogenous long-chain polyu... : Current Opinion in Clinical
Nutrition & Metabolic Care Desaturase and elongase-limiting endogenous long-chain …
Nutrition & Metabolic Care Desaturase and elongase-limiting endogenous long-chain …
Novel cellular functions of very long chain-fatty acids: insight from ELOVL4 mutations
F Deák, RE Anderson, JL Fessler… - Frontiers in cellular …, 2019 - frontiersin.org
Elongation of Very Long chain fatty acids-4 (ELOVL4) protein is a member of the ELOVL
family of fatty acid elongases that is collectively responsible for catalyzing formation of long …
family of fatty acid elongases that is collectively responsible for catalyzing formation of long …
A pentanucleotide ATTTC repeat insertion in the non-coding region of DAB1, mapping to SCA37, causes spinocerebellar ataxia
AI Seixas, JR Loureiro, C Costa… - The American Journal of …, 2017 - cell.com
Advances in human genetics in recent years have largely been driven by next-generation
sequencing (NGS); however, the discovery of disease-related gene mutations has been …
sequencing (NGS); however, the discovery of disease-related gene mutations has been …
Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia
EAR Nibbeling, A Duarri, CC Verschuuren-Bemelmans… - Brain, 2017 - academic.oup.com
The autosomal dominant cerebellar ataxias, referred to as spinocerebellar ataxias in genetic
nomenclature, are a rare group of progressive neurodegenerative disorders characterized …
nomenclature, are a rare group of progressive neurodegenerative disorders characterized …
A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies
M Coutelier, G Coarelli, ML Monin, J Konop… - Brain, 2017 - academic.oup.com
Autosomal dominant cerebellar ataxias have a marked heterogeneous genetic background,
with mutations in 34 genes identified so far. This large amount of implicated genes accounts …
with mutations in 34 genes identified so far. This large amount of implicated genes accounts …
Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia
A Benussi, V Dell'Era, MS Cotelli, M Turla, C Casali… - Brain stimulation, 2017 - Elsevier
Background Neurodegenerative cerebellar ataxias represent a group of disabling disorders
for which we currently lack effective therapies. Cerebellar transcranial direct current …
for which we currently lack effective therapies. Cerebellar transcranial direct current …
Cerebello-spinal tDCS in ataxia: a randomized, double-blind, sham-controlled, crossover trial
A Benussi, V Dell'Era, V Cantoni, E Bonetta, R Grasso… - Neurology, 2018 - AAN Enterprises
Objective To investigate whether a 2-week treatment with cerebellar anodal and spinal
cathodal transcranial direct current stimulation (tDCS) could reduce symptoms in patients …
cathodal transcranial direct current stimulation (tDCS) could reduce symptoms in patients …